Biomatlante SA:企業の製品パイプライン分析

◆英語タイトル:Biomatlante SA - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME9653PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw and membrane, among others. Its products are used in stomatology, dental regenerative, sports surgery, spine surgery and orthopaedics. Biomatlante’s leverages Micro Macroporous Biphasic Calcium Phosphate (MBCP) technology for the development of products. The company works in collaboration with universities and research centers such as National Institute of Health and Medical Research, French National Center for Scientific Research, and other national and international universities for the development of novel projects. Biomatlante is headquartered in Vigneux de Bretagne, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biomatlante SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Biomatlante SA Company Overview
Biomatlante SA Company Snapshot
Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview
Biomatlante SA – Pipeline Analysis Overview
Biomatlante SA – Key Facts
Biomatlante SA – Major Products and Services
Biomatlante SA Pipeline Products by Development Stage
Biomatlante SA Pipeline Products Overview
Biological Grafts
Biological Grafts Product Overview
Gene-Activated Matrix
Gene-Activated Matrix Product Overview
Hydrogels
Hydrogels Product Overview
Osteoconductive Resorbable Composite
Osteoconductive Resorbable Composite Product Overview
Biomatlante SA – Key Competitors
Biomatlante SA – Key Employees
Biomatlante SA – Locations And Subsidiaries
Head Office
Recent Developments
Biomatlante SA, Recent Developments
Jun 01, 2015: BIOMATLANTE obtains CE approval to market its OSTEOTWIN Affix Sheath
Jan 17, 2013: Biomatlante Gets ANSM Approval For REBORNE Project
Oct 25, 2012: Biomatlante Announces Successful FDA QSIT Inspection
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview
Biomatlante SA Pipeline Products by Equipment Type
Biomatlante SA Pipeline Products by Indication
Biomatlante SA, Key Facts
Biomatlante SA, Major Products and Services
Biomatlante SA Number of Pipeline Products by Development Stage
Biomatlante SA Pipeline Products Summary by Development Stage
Biological Grafts - Product Status
Biological Grafts - Product Description
Gene-Activated Matrix - Product Status
Gene-Activated Matrix - Product Description
Hydrogels - Product Status
Hydrogels - Product Description
Osteoconductive Resorbable Composite - Product Status
Osteoconductive Resorbable Composite - Product Description
Biomatlante SA, Key Employees
Glossary

★海外企業調査レポート[Biomatlante SA:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MAXrad SOFTware (India) Pvt. Ltd.:企業の戦略・SWOT・財務情報
    MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Saudi Arabian Mining Co:企業の戦略・SWOT・財務情報
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • American Express Company:企業のM&A・事業提携・投資動向
    American Express Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Express Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nuo Therapeutics Inc (AURX):企業の財務・戦略的SWOT分析
    Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Breg Inc-医療機器分野:企業M&A・提携分析
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes cold therapy products. The company offers products, which include cold therapy products, hip braces, elbow or wrist braces, knee braces, shoulder braces, spine braces, ankle braces, home therapy kits, and others. I …
  • Opus International Consultants Ltd:企業の戦略・SWOT・財務情報
    Opus International Consultants Ltd - Strategy, SWOT and Corporate Finance Report Summary Opus International Consultants Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MediGene AG (MDG1):企業の財務・戦略的SWOT分析
    MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Benihana Inc.:企業の戦略・SWOT・財務情報
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • Nippon Soda Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆